openPR Logo
Press release

Global Psoriasis Market To Witness Incremental Growth In The Forecast Period

04-11-2022 05:57 AM CET | Health & Medicine

Press release from: The Business research company

Psoriasis Drugs Market

Psoriasis Drugs Market

Psoriasis Global Market Report 2022 - Market Size, Trends, And Global Forecast 2022-2026 by The Business Research Company is the most comprehensive report available on this market, with analysis of the market's historic and forecast growth, drivers and restraints causing it, and highlights of the opportunities that companies in the industry can take on. The psoriasis market research report helps gain a truly global perspective of the psoriasis industry as it covers 60 geographies worldwide. Regional and country breakdowns give an analysis of the market in each geography, with information on the size of the market by region and by country.

The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. Among these regions, North America accounts for the largest psoriasis market share.

Request For A Sample Of The Psoriasis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

The psoriasis market consists of sales of psoriasis drugs. Psoriasis is a persistent skin disorder which causes distress and pain through patches of abnormal skin. Psoriasis can be caused due to injuries to skin, medications, genetics, infection, diet, weather, etc. The drugs vary depending on the severity of the infection and provide relief from infections. Examples of drugs in the psoriasis market include clobetasol (Temovate), triamcinolone (Aristocort), fluocinolone (Synalar), and betamethasone (Diprolene).

Key competitors in the psoriasis market include AbbVie Inc., Pfizer Inc., Novartis, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co Inc. and Janssen Biotech.

The global psoriasis market size is expected to grow from $17.67 billion in 2021 to $19.98 billion in 2022 at a compound annual growth rate (CAGR) of 13.1%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global psoriasis market is expected to reach $30.90 billion in 2026 at a CAGR of 11.5%.

Need more for your business growth? Directly purchase the report here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2414

TBRC's report segments the global psoriasis market:
1) By Drug Class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor
2) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce
3) By Drug Type: Small Molecules, Biologics
4) By Route of Administration: Oral, Tropical, Injectable
5) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis

Read Further On The Psoriasis Market Here:
https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report

The Table of Contents includes:
1. Executive Summary
2. Psoriasis Drugs Market Characteristics
3. Psoriasis Drugs Market Trends And Strategies
4. Impact Of COVID-19 On Psoriasis Drugs
5. Psoriasis Drugs Market Size And Growth
.....
28. Psoriasis Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The Psoriasis Drugs Market
30. Psoriasis Drugs Market Future Outlook and Potential Analysis
31. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
And check out our Blog: http://blog.tbrc.info/

Interested to know more about The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally, it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Psoriasis Market To Witness Incremental Growth In The Forecast Period here

News-ID: 2599337 • Views:

More Releases from The Business research company

Outlook for the Ready To Drink (RTD) Alcoholic Beverages Market: Major Segments, Strategic Developments, and Leading Companies
Outlook for the Ready To Drink (RTD) Alcoholic Beverages Market: Major Segments, …
The ready-to-drink (RTD) alcoholic beverages market is on track to experience significant growth over the coming years, driven by evolving consumer preferences and industry innovations. This sector is rapidly expanding as more consumers seek premium, convenient, and sustainable options in their alcoholic beverage choices. Let's explore the market's projected size, key drivers, major players, emerging trends, and segmentation details shaping its future. Projected Expansion and Market Size of the Ready To
Emerging Sub-Segments Transforming the Pumpkin Seed Protein Market Landscape
Emerging Sub-Segments Transforming the Pumpkin Seed Protein Market Landscape
The pumpkin seed protein market is emerging as a promising sector within the broader landscape of plant-based proteins. With increasing consumer interest in alternative, allergen-free protein sources and sustainable nutrition, this market is set to witness substantial growth and innovation. Let's explore the market size projections, key players, current trends, and major product segments shaping the future of pumpkin seed protein. Projected Market Valuation and Growth Expectations for Pumpkin Seed Protein
Top Players and Market Competition in the Protein Hydrolysates Industry
Top Players and Market Competition in the Protein Hydrolysates Industry
The protein hydrolysates market is positioned for significant expansion in the coming years as consumer preferences and nutritional science continue to evolve. With increasing attention on tailored nutrition solutions and the rise of plant-based options, this market is gearing up for robust growth and innovation. Protein Hydrolysates Market Size Projections Through 2030 The protein hydrolysates market is forecasted to grow substantially, reaching a value of $7.25 billion by 2030. This
Processed Meat Market Overview: Major Segments, Strategic Developments, and Leading Companies
Processed Meat Market Overview: Major Segments, Strategic Developments, and Lead …
The processed meat industry is positioned for substantial expansion over the coming years, driven by evolving consumer preferences and technological advancements. As the market adapts to changing demands and regulatory landscapes, it is expected to reach impressive valuation milestones. Let's explore the current market size, key players, emerging trends, and detailed segment analyses shaping this sector's future. Forecasted Market Size and Growth Trajectory of the Processed Meat Market The processed

All 5 Releases


More Releases for Psoriasis

Prevalence Of Psoriasis Driving Market Growth: A Key Catalyst Accelerating Psori …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025? Over the recent years, there has been a robust growth in the size of the psoriasis market. It is estimated to rise from $26.45 billion in 2024 to $28.93 billion in 2025, with a compound annual
Psoriasis Vulgaris Market
Introduction Psoriasis vulgaris, also known as plaque psoriasis, is the most common form of psoriasis, accounting for nearly 80-90% of all cases. It is a chronic autoimmune condition marked by red, scaly plaques that can cause significant physical discomfort and emotional distress. Affecting millions worldwide, psoriasis vulgaris is increasingly recognized as both a dermatological and systemic disease due to its association with arthritis, cardiovascular disease, and metabolic syndrome. The global psoriasis vulgaris
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Psoriasis Market Size During the Forecast Period? The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally. Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It